Systematic Financial Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-20,105
Closed -$2.93M 693
2017
Q3
$2.93M Sell
20,105
-1,504
-7% -$205K 0.06% 238
2017
Q2
$2.81M Sell
21,609
-1,310
-6% -$161K 0.05% 311
2017
Q1
$2.85M Sell
22,919
-36,345
-61% -$4.35M 0.05% 300
2016
Q4
$6.86M Buy
+59,264
New +$6.6M 0.11% 228
2013
Q4
Sell
-156,260
Closed -$12M 757
2013
Q3
$12M Buy
+156,260
New +$11M 0.1% 214

Other funds holding CELG

Systematic Financial Management's CELG Position: Q4 2017 in Review

Systematic Financial Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 20,105 shares — an estimated $2.93M sold.

Systematic Financial Management first reported a position in CELG in Q3 2013 and held it in 5 quarters. The position peaked at $12M in Q3 2013. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Systematic Financial Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Systematic Financial Management sold 20,105 Celgene Corp shares in Q4 2017, an estimated $2.93M.
  • Systematic Financial Management first reported a position in Celgene Corp in Q3 2013 and held it in 5 quarters.
  • Systematic Financial Management's Celgene Corp position peaked at $12M in Q3 2013.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Systematic Financial Management's 13F filing for Q4 2017, filed 9 Feb 2018.